There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
41253.53 Cr.Face value
10.00Book value
281.69Div. yield
0.17%P/E ratio
37.73P/B ratio
7.72Debt/Eq.
0.24Market Cap
41253.53 Cr.Face value
10.00Book value
281.69Div. yield
0.17%P/E ratio
37.73P/B ratio
7.72Debt/Eq.
0.24
| Sep 26 | Jun 26 | Change | |
|---|---|---|---|
| Promoter Holdings | 77.82% | 77.83% | -0.01% |
| Promoter Pledge | 0.04% | 0.04% | 0.00% |
Emcure Pharmaceuticals Ltd has delivered a return of 10.28% over the last 3 months. The stock was trading at ₹1,959.00 on 05 Aug 2026 and is currently at ₹2,245.00 as of 05 Nov 2026, reflecting a Gain of ₹286.00 per share over this period.
The intraday high for Emcure Pharmaceuticals Ltd on the NSE today (05 Nov 2026) was ₹2,266.40. This compares to the 52-week high of ₹2,174.20 recorded on 04 Nov 2026. Today's high was 4.24% above the 52-week high.
Emcure Pharmaceuticals Ltd has delivered a N/A% absolute return over the past 5 years, equivalent to a CAGR of N/A% per annum. The stock was priced at ₹N/A in Nov 2021 and has fallen to ₹2,245.00 as of 05 Nov 2026. An investment of ₹1,00,000 in Emcure Pharmaceuticals Ltd five years ago would be worth ₹N/A today.
No,Emcure Pharmaceuticals Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of 6.60 per share between FY2022 and FY2026, with the most recent dividend of ₹3.60 per share for May 26, with an ex-dividend date of 04 Sep 2026. At the current market price of ₹2,245.00, the trailing dividend yield of Emcure Pharmaceuticals Ltd stands at 3.60%.
As of 05 Nov 2026, the share price of Emcure Pharmaceuticals Ltd is ₹2,245.00 on the NSE and ₹2,221.00 on the BSE. The stock opened at ₹2,179.00, touched a high of ₹2,266.40 and a low of ₹2,143.00 during today's session.
Over the last 6 months, Emcure Pharmaceuticals Ltd has given a return of 27.81%. The stock was priced at ₹1,690.30 on 05 May 2026 and has Rise to ₹2,245.00 as of 05 Nov 2026, a change of ₹554.70 per share.
The intraday low for Emcure Pharmaceuticals Ltd on the NSE today was ₹2,143.00. The stock's 52-week low stands at ₹1,312.30, recorded on 26 Nov 2025. Today's low is 63.30% above the 52-week low, indicating the stock is trading well above its yearly lows.
Emcure Pharmaceuticals Ltd has delivered 58.97% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,174.20 on 04 Nov 2026 and a 52-week low of ₹1,312.30 on 26 Nov 2025. It is currently trading at ₹2,245.00 as of 05 Nov 2026.
The all-time high (ATH) for Emcure Pharmaceuticals Ltd was ₹2,160.40, recorded on 04 Nov 2026. At the current price of ₹2,245.00, the stock is trading -3.92% below its all-time high. The all-time low recorded was ₹905.60 on 09 Apr 2025.
For Q2 FY27, Emcure Pharmaceuticals Ltd reported: Revenue (Net Sales): ₹16679.84 Cr - Up 14.96% year-on-year from ₹14509.31 Cr in Q1 FY27. Net Income (PAT): ₹2484.28 Cr - Up 24.15% year-on-year from ₹2001.08 Cr in Q1 FY27.
